Using photoacoustic imaging to diagnose skin cancer
Photoacoustic Imaging for Three-dimensional Delineation of Skin Tumors
This study is testing a new imaging technique to see if it can help doctors better identify different types of skin cancer in patients who might have it.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 200 (estimated) |
| Sex | All |
| Sponsor | Region Skane Academic / other |
| Locations | 1 site (Lund) |
| Trial ID | NCT06379581 on ClinicalTrials.gov |
What this trial studies
This clinical study utilizes photoacoustic imaging to assess patients with suspected skin cancer, focusing on melanoma, basal cell carcinoma, and squamous cell carcinoma. The approach involves scanning suspected tumors using multispectral photoacoustic imaging to identify tumor borders both superficially and at depth. By analyzing hyperspectral data and employing a classification algorithm, the study aims to create a 3D image that distinctly contrasts tumors from healthy tissue, potentially improving diagnostic accuracy and efficiency.
Who should consider this trial
Good fit: Ideal candidates are patients scheduled for surgical excision of lesions suspected to be tumors.
Not a fit: Patients with no lesions suspected to be tumors or those not scheduled for surgical excision may not benefit from this study.
Why it matters
Potential benefit: If successful, this method could significantly enhance the accuracy and speed of skin cancer diagnoses, leading to better patient outcomes.
How similar studies have performed: While the use of photoacoustic imaging is a relatively novel approach in skin cancer diagnostics, similar imaging techniques have shown promise in other studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients scheduled to perform surgical excision of lesion(s) suspected to be tumors. Exclusion Criteria: -
Where this trial is running
Lund
- Department of Ophthamology, Lund, Skåne University Hospital — Lund, Sweden (Recruiting)
Study contacts
- Study coordinator: John Albinsson, PhD
- Email: john.albinsson@med.lu.se
- Phone: 0702497057
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.